Clinical trial / 1993
A 12-week regimen of garlic powder tablets increased walking distance in patients with stage II peripheral arterial occlusive disease.
Patients with stage II peripheral arterial occlusive disease received either 800 mg of garlic powder daily or a placebo for 12 weeks, with both groups undergoing physical therapy twice weekly. The increase in walking distance was significantly higher (P < 0.05) in the garlic group (by 46 m, from 161.0 +/- 65.1 to 207.1 +/- 85.0 m) compared with the placebo group (by 31 m, from 172.0 +/- 60.9 to 203.1 +/- 72.8 m). Diastolic blood pressure, spontaneous thrombocyte aggregation, plasma viscosity, and cholesterol concentration also decreased significantly, while body weight was maintained. The garlic-specific increase in walking distance did not appear until the 5th week of treatment, coinciding with a decrease in spontaneous thrombocyte aggregation.
- Study type
- Randomized controlled trial
- Who was studied
- Patients with peripheral arterial occlusive disease stage II
- What was measured
- Walking distance, blood pressure, thrombocyte aggregation, plasma viscosity, cholesterol
THE PAPER
Effects of garlic coated tablets in peripheral arterial occlusive disease.
Kiesewetter H, Jung F, Jung EM, Blume J, Mrowietz C, Birk A, Koscielny J, Wenzel E. Clin Investig, 1993.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.